top of page

Welcome to ELSIE

The Extractables and Leachables Safety Information Exchange (ELSIE) Consortium formed in 2007 seeking to be the leading industry voice and scientific resource on extractables and leachables (E&L). The consortium is comprised of pharmaceutical, biotechnology, and medical device companies.

The ELSIE Consortium

  • Collects, reviews, and compiles toxicological data on leachables and extractables in an information-rich database, enabling rigorous assessments.

  • Advances understanding of the impact of extractables and leachables on product quality and process performance.

  • Provides opportunities to share and leverage experiences, insights, and practices with respect to the potential safety impact of drug product packaging, delivery and manufacturing systems.

  • Advances the state of the art in chemical/toxicological assessment of leachables and extractables by supporting and publishing research and participating in the global scientific and regulatory communities.

2022 Year in Review

strategic plan.PNG

The ELSIE Consortium is proud to acknowledge the dedication and commitment of its members. Each year ELSIE presents awards to participants who made significant contributions to ELSIE initiatives. 

In 2022 the ELSIE Chair Awards went to Melisa Masuda-Herrera (Gilead Sciences) and Petra Booij (GSK) for their outstanding leadership and many contributions.

2022 ​ELSIE Excellence Recognition Awards Recipients:

  • Atish Sen (AstraZeneca)

  • Geraldine Whelan (GSK)

  • Stephen Warren (AstraZeneca)

  • Martyn Chilton (Lhasa Limited)

  • Carsten Worsøe (Novo Nordisk)

  • The ELSIE Sensitization Subteam

  • The ELSIE TTC Subteam

ELSIE Members:

Click here for an overview of ELSIE Membership options.

bottom of page